MIRM vs NVO
Mirum Pharmaceuticals Inc (MIRM) versus NVO (NVO) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
NVO (NVO) common stock.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
NVO does not have a complete income-statement cache yet.
MIRM currently screens at market cap $6.22B. NVO currently screens at market cap $0.
Not investment advice. Open the MIRM and NVO stock pages for the full models.
Not investment advice.